Clinical trial
Effects of Angiotensin Converting Enzyme Inhibitor Therapy on Vascular Inflammation and Compliance
NCT00005928 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Angiotensin Converting Enzyme Inhibitor Therapy on Vascular Inflammation and Compliance
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2000
- Completion date
- February 28, 2002
- Enrollment
- 25
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.